We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

By LabMedica International staff writers
Posted on 20 Jun 2025

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. More...

Since most treatments only slow disease progression, early diagnosis is critical for effective care. Now, researchers have developed a novel and affordable screening system that detects PD from the volatile organic compounds (VOCs) found in a person’s earwax.

This innovative approach from researchers at Zhejiang University (Hangzhou, China;) was the result of a study to explore the diagnostic potential of sebum-rich earwax as a more stable and protected source of VOCs linked to Parkinson’s. The idea builds on earlier findings that sebum composition changes in PD due to neurodegeneration, inflammation, and oxidative stress, resulting in a distinctive odor profile. Unlike facial sebum, which is exposed to external environmental conditions such as humidity and air pollution, earwax remains relatively uncontaminated, making it a reliable testing medium. To investigate this, the researchers collected earwax samples by swabbing the ear canals of 209 individuals, including 108 people diagnosed with PD. Using gas chromatography and mass spectrometry, they identified four VOCs that were significantly different in people with Parkinson’s: ethylbenzene, 4-ethyltoluene, pentanal, and 2-pentadecyl-1,3-dioxolane. These VOCs emerged as potential biomarkers for the disease.

Based on this dataset, the team developed an artificial intelligence olfactory (AIO) system trained to detect PD by analyzing the VOC patterns. When tested, the AIO-based model demonstrated 94% accuracy in distinguishing between PD and non-PD samples, according to the ACS’ Analytical Chemistry report. The high level of precision highlights the system’s potential for early detection, especially since the test is non-invasive and inexpensive. This new AIO screening tool could serve as a first-line diagnostic method to catch PD in its earliest stages, well before traditional symptoms appear. By enabling earlier medical intervention, it may improve long-term care outcomes for patients and streamline diagnosis in both clinical and community healthcare settings.

“This method is a small-scale single-center experiment in China,” said researcher Hao Dong from Zhejiang University. “The next step is to conduct further research at different stages of the disease, in multiple research centers and among multiple ethnic groups, in order to determine whether this method has greater practical application value.”


New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Alcohol Testing Device
Dräger Alcotest 7000
New
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.